Meryll Dindin

I'm an AI researcher who builds. I started in machine-learning research (arrhythmia detection at Fujitsu's Tokyo lab, on a granted patent and a University of Tokyo clinical trial) and have spent a decade putting ML where the stakes are real: clinical diagnostics, emergency dispatch, manufacturing, and now K-12 education.

I also run a quantified longevity program on myself. Biological age, VO2 max, DXA, continuous glucose, and labs kept longitudinal since 2022. I write about what the data actually shows, not what the supplement industry sells, at merylldindin.com.

Today I lead product and engineering at Parallel Learning, a K-12 teletherapy platform across 27+ states, where I built the Pathway platform from scratch and led our ISO 27001 certification. Before that I co-founded Polygon, a remote ADHD and dyslexia diagnostics practice backed by Spark Capital, where we cut evaluations from a six-month wait to two weeks.

Ask me about applied AI, longevity, and building products in regulated healthcare and education.